Table 2.
Primer name and variant changes | Primer sequence | Concentration (μM) |
---|---|---|
Splice site mutation | 5′-CCTATCCTTGTCGGT-3′ | 0.4 |
c.253-2A>G | ||
IVS 2-2A>G | ||
Exon5 c.404C>T p.S135L | 5′-AGGTCATGTGCTTCCACCCCTGGT-3′ | 0.2 |
Exon5 c.413C>T* p.T138M | 5′-GGATCTCAGGGACCGACATGAGTGGCAGC-3′ | 0.08 |
Exon6 c.563A>G p.Q188R | 5′-ATGATGGGCTGTTCTAACCCCCACCCCCACTGCC-3′ | 0.1 |
Exon7 c.584T>C p.L195P | 5′-CTGCTTTTGCCCCTTGACAGGTATGGGCCAGCAGTTTCC-3′ | 0.36 |
Exon7 c.626A>G*p.Y209C | 5′-GGCGGCTGTACTCCATTAGCAGGGGCTCTCCATGCTGACTCTTA-3′ | 0.4 |
Exon7 c.652C>T*†p.L218L | 5′-TTGGCTCTCTCCCACCTTCCTGAGTAGCTCCTGGCGGCTGTACTCCATTA-3′ | 0.16 |
Exon9 c.285G>T† p.K285N | 5′-GAGTCAGGCTCTGATTCCAGATCTAGCCTCCATCATGAAGAAGCTCTTGACCAA-3′ | 0.12 |
Exon10 c.940A>G† p.N314D | 5′-CACTGTCTCTCTTCTTTCTGTCAGGGGCTCCCACAGGATCAGAGGCTGGGGCCAACTGG-3′ | 0.4 |
Exon number, nucleotide, and amino acid changes are given with primer sequences and concentrations of nine oligodeoxyribonucleotides.
Primers in italics interrogate the antisense strand.
Primers that are 50-bp long were purified by high-performance liquid chromatography before use.